Detalhe da pesquisa
1.
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.
Mol Cell;
78(6): 1096-1113.e8, 2020 06 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32416067
2.
Cancer-stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies.
Proc Natl Acad Sci U S A;
121(20): e2322688121, 2024 May 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38709925
3.
Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progression.
Proc Natl Acad Sci U S A;
120(49): e2316763120, 2023 Dec 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38011567
4.
Inhibition of EZH2 transactivation function sensitizes solid tumors to genotoxic stress.
Proc Natl Acad Sci U S A;
119(3)2022 01 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35031563
5.
TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer.
Breast Cancer Res;
26(1): 20, 2024 01 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38297352
6.
BRCA1/FANCD2/BRG1-Driven DNA Repair Stabilizes the Differentiation State of Human Mammary Epithelial Cells.
Mol Cell;
63(2): 277-292, 2016 07 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27373334
7.
The epithelial-mesenchymal transition generates cells with properties of stem cells.
Cell;
133(4): 704-15, 2008 May 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18485877
8.
The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival.
Nature;
546(7658): 426-430, 2017 06 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28607489
9.
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer.
Nature;
529(7586): 413-417, 2016 Jan 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26735014
10.
Deletion of Cdkn1b in ACI rats leads to increased proliferation and pregnancy-associated changes in the mammary gland due to perturbed systemic endocrine environment.
PLoS Genet;
15(3): e1008002, 2019 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30893315
11.
Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity.
Nature;
514(7520): 54-8, 2014 Oct 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25079331
12.
Oncogene-like induction of cellular invasion from centrosome amplification.
Nature;
510(7503): 167-71, 2014 Jun 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24739973
13.
Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion.
J Pathol;
243(4): 496-509, 2017 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29086922
14.
Sequence analysis of mutations and translocations across breast cancer subtypes.
Nature;
486(7403): 405-9, 2012 Jun 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22722202
15.
Intratumor Heterogeneity in Breast Cancer.
Adv Exp Med Biol;
882: 169-89, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26987535
16.
Histone demethylase jumonji AT-rich interactive domain 1B (JARID1B) controls mammary gland development by regulating key developmental and lineage specification genes.
J Biol Chem;
289(25): 17620-33, 2014 Jun 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24802759
17.
Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling.
BMC Cancer;
15: 70, 2015 Feb 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25879571
18.
Molecular definition of breast tumor heterogeneity.
Cancer Cell;
11(3): 259-73, 2007 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17349583
19.
Cancer: Clonal cooperation.
Nature;
508(7494): 52-3, 2014 Apr 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24695309
20.
The receptor tyrosine kinase ErbB3 maintains the balance between luminal and basal breast epithelium.
Proc Natl Acad Sci U S A;
109(1): 221-6, 2012 Jan 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22178756